Inventor

BRAMS PETER

DE59 patents

⚠️ This page may combine multiple inventors who share the name “BRAMS PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRAMS PETER

BIOGEN IDEC INC

CD80 specific antibodies

Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4

Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4

Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies

Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies

Host cells expressing 7C10 and 16C10 CD80-specific antibodies

7C10 and 16C10 CD80-specific antibodies

Anti-CD80 antibodies

Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies

Methods of producing 7C10 and 16C10 CD80-specific antibodies

Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies

IDEC PHARMA CORP

Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

KRAUSS MAFFEI AG

Pressure and alignment compensator for a press

Apparatus for feeding synthetic resin material to injection molding and extruder units

Apparatus for the plastifying of thermoplastic synthetic resins

Apparatus for making a composite thermoplastic and silicone article

Mold centering system for injection-molding machine

Closing apparatus for multiple-mold injection-molding system

Device for charging injection molding and extruding machines and having a funnel provided with pins passing through clearances in a feed worm

SCHERING CORP

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

(unassigned)

Methods for treating b cell lymphoma using CD80-specific antibodies

Treatment of psoriasis using anti-B7.1 (CD80) antibodies

Method of manufacturing an article of jewelry having faux pave look

PFIZER

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

Binding molecules to the human OX40 receptor

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

SQUIBB & SONS LLC

Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies

Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM1 antibodies

Human monoclonal antibodies that bind CXCR4 and uses thereof

MEDAREX INC

Transgenic animals expressing chimeric antibodies for use in preparing human antibodies

Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1

MIN JING

Binding molecules to the human OX40 receptor

Binding molecules to the human OX40 receptor

TANAMACHI DAWN M

Transgenic animals expressing chimeric antibodies for use in preparing human antibodies

Transgenic animals expressing chimeric antibodies for use in preparing human antibodies

BRISTOL MYERS SQUIBB CO

Binding molecules to the human OX40 receptor

XENEREX BIOSCIENCES

Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

KUHNE MICHELLE

Human monoclonal antibodies that bind CXCR4

UNIV LELAND STANFORD JUNIOR

Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3)

WANG YAN

Neutralizing human anti-IGFR antibody